title: Dual Antiplatelet Therapy Duration Following Coronary Stenting. [Corrected].
authors.affiliation: Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Robert W
authors.initials: RW
authors.lastname: Yeh
authors.affiliation: Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Laura
authors.initials: L
authors.lastname: Mauri
authors.affiliation: The Christ Hospital Heart and Vascular Center/The Lindner Research Center, Cincinnati, Ohio. Electronic address: lindner@thechristhospital.com.
authors.forename: Dean J
authors.initials: DJ
authors.lastname: Kereiakes
mesh_terms: D001241:Aspirin; D000077144:Clopidogrel; D003324:Coronary Artery Disease / Q000628:therapy*; D023903:Coronary Restenosis; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D005260:Female; D006470:Hemorrhage; D006801:Humans; D008297:Male; D062645:Percutaneous Coronary Intervention; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin
keywords: drug-eluting stent(s); percutaneous coronary angioplasty